Kalbe Farma Gains to Five-Week High as Nine-Month Profit Jumps

PT Kalbe Farma rose to a five-week high in Jakarta trading after it reported that January through September unaudited net income rose to 1.07 trillion rupiah from 902 billion rupiah in the same period a year earlier.

The Indonesian pharmaceutical company advanced 1.4 percent to 3,525 rupiah as of 9:58 a.m. local time, set for the highest close since Sept. 16.

To contact the reporter on this story: Femi Adi in Jakarta at fadi1@bloomberg.net

To contact the editor responsible for this story: Andrew Janes at ajanes@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.